The UChicago-backed digital home insurance provider is joining forces with Omnichannel Acquisition Corp at a valuation of just over $1bn.

Harvard spinout TScan Therapeutics has successfully listed on the Nasdaq Global Market.

The Salesforce-backed banking software producer floated at the top of its range and saw its shares rise on their first day of trading.

The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.

Pharmaron, Celgene, Amgen and Merck & Co-backed Imago BioSciences floated in an IPO today, alongside a private placement transaction featuring Pfizer.

The IGBMC spinout was set up by Satt Conectus and is now seeking a listing in the US with a price range of $15 to $17.

The Ant Group, Info Edge and Delivery Hero-backed restaurant listings and food delivery app operator is floating in a dual listing, having secured $562m from anchor investors yesterday.

Th heart disease treatment developer has secured $248m in funding since being formed to exploit UT Southwestern and Gladstone Institute research.

The Mitsui-backed online money transfer service has taken an LSE spot and had a $12bn market capitalisation following its first day of trading.

University of Washington spinout Icosavax has filed for an initial public offering on the Nasdaq Global Select Market, with financial terms yet to be set.